Phenylethylmalonamide in essential tremor. A double-blind controlled study.

A randomised double-blind placebo-controlled trial of phenylethylmalonamide, the major metabolite of primidone was performed in eight patients with essential tremor. Phenylethylmalonamide was given in a daily dose of 400 mg for one week and 800 mg for a second week. The compound had no statistically...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	J Neurol Neurosurg Psychiatry
Hauptverfasser:	Calzetti, S, Findley, L J, Pisani, F, Richens, A
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMJ Publishing Group 1981
Schlagworte:	Research Article
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC491180/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7031184/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jnnp.44.10.932
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!